Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CLX✓SelectedUSD · CLXMRNA vs CLX performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs CLX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+772.1%
CLX return
+11.9%
Excess return
+760.2%
Maximum drawdown
-34.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioCLXExcessAlpha
1D-2.2%-0.2%-2.0%-2.1%
7D-12.7%-4.3%-8.4%-10.9%
30D-20.7%+25.3%-46.0%-29.2%
3M+46.3%+0.2%+46.1%+47.1%
6M+305.2%+14.0%+291.2%+309.3%
YTD+561.2%+9.1%+552.1%+564.8%
1Y+772.1%+10.0%+762.1%+774.3%
All+772.1%+11.9%+760.2%+774.3%

Cumulative growth

Daily Returns

Daily percentage return beside CLX.

Daily Out/Under-Performance

Portfolio return minus CLX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CLX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded CLX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling